ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA approves first treatment for severe hypoglycemia that can be administered without an injection
July 30, 2019The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without ... -
Eli Lilly’s BAQSIMI nasal powder set to treat severe hypoglycemia
July 28, 2019It is compact, portable and ready to use (no reconstitution required) in a single, fixed, 3 mg dose -
FDA Approves New Severe Hypoglycemia Treatment
July 26, 2019The U.S. Food and Drug Administration (FDA) approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
Pharma Sources Insight January 2025
